Friday 12th July
08:00		Badge Collection and Welcome Coffee
08:30		Introduction Professor Derek Yellon University College London, UK
08:45		Session 1 The role of The Lancet in the modern era Dr Richard Horton Editor-in-Chief of the Lancet, London UK
09:25		Surprising findings from clinical trials – cardiology, diabetes & nephrology Professor Marc Pfeffer Harvard University, Boston, USA
10:05		Primordial cardiology in youth – what are the limits? Professor John Deanfield University College London, UK
10:45		Break
11:15		Session 2 Haplotypes and pathophysiological clusters of diabetes in Latin America: are we part of the same world tribe? Professor Carlos Aguilar-Salinas Instituto Nacional de Ciencias Médicas y Nutrición, México City, México
11:55		Industry symposium: Novo Nordisk
13:10		Lunch
14:10		Session 3 Trials and Tribulations in AKI. Do we know where we are going? Professor Steven Weisbord VA Pittsburgh Healthcare System, USA
14:50		Sudden cardiac death at the limits Professor Perry Elliot University College London, UK
15:30		Modern drug therapy for type 2 diabetes – GLP-1 analogues & SGLT2 inhibitors Professor Mansoor Husain University of Toronto, Canada
16:10		Close
Saturday 13th July
08:00		Welcome Coffee
08:30		Session 5 Have we reached the limits of lipid lowering and outcome? Professor Raul Santos University of Sao Paulo, Brazil
09:10		Cardiac atheroma at the limits – are we fighting the final battle? Professor Peter Libby The Brigham & Women’s Hospital, Harvard Medical School, Boston, USA
09:50		Heart failure therapy – extending the limits! Professor John McMurray University of Glasgow, Scotland
10:50		Break
11:00		Session 6 HDL – its role in myocardial infarction - where do we stand? Professor Andrei Sposito University of Campinas, Brazil
11:40		Comfort Break
11:50		Session 7 Industry symposium: AstraZeneca
13:05		Lunch
14:05		Session 8 Targets for primary hypertension with and without comorbidities Professor Brian Rayner University of Cape Town, SA
14:45		The central control of obesity Professor Licio Velloso University of Campinas, Brazil
15:25		Cross talk between bone, kidney and vasculature Professor John Cunningham University College London, UK

Endorsed by:

Cardiology, Diabetes & Nephrology at the Limits Brazil is supported by educational grants from the Pharmaceutical Industry.

A list of 2019 supporters is HERE